Robert Deicher

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi Neutrophil beta(2)-microglobulin and lactoferrin content in renal failure patients
    R Deicher
    Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Wein, Austria
    Am J Kidney Dis 35:1117-26. 2000
  2. ncbi Intravenous iron: the iatrogenic kick to lose control over oxygen?
    R Deicher
    Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Wien, Osterreich
    Kidney Blood Press Res 25:284-8. 2002
  3. ncbi Vitamin C in chronic kidney disease and hemodialysis patients
    Robert Deicher
    Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Wien, Osterreich
    Kidney Blood Press Res 26:100-6. 2003
  4. ncbi High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity
    Robert Deicher
    Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria
    Kidney Int 64:728-36. 2003
  5. ncbi Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis
    Robert Deicher
    Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Nephrol Dial Transplant 19:2319-24. 2004
  6. ncbi Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease
    Robert Deicher
    Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria
    Drugs 64:499-509. 2004
  7. ncbi Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients
    Robert Deicher
    Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria
    J Am Soc Nephrol 16:1811-8. 2005
  8. ncbi The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients
    Gerald Cohen
    Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria
    Nephrol Dial Transplant 23:2512-9. 2008
  9. ncbi Anaemia as a risk factor for the progression of chronic kidney disease
    Robert Deicher
    Department of Medicine III, Division of Nephrology and Dialysis, University Hospital of Vienna, Austria
    Curr Opin Nephrol Hypertens 12:139-43. 2003
  10. ncbi Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis
    Bernhard Moser
    Department of Surgery, General Hospital of Vienna, Austria
    Biochem Biophys Res Commun 308:581-5. 2003

Collaborators

Detail Information

Publications12

  1. ncbi Neutrophil beta(2)-microglobulin and lactoferrin content in renal failure patients
    R Deicher
    Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Wein, Austria
    Am J Kidney Dis 35:1117-26. 2000
    ..These data indicate abnormalities in uremic patients of PMNL granule lactoferrin content and release that are reversible after successful renal transplantation...
  2. ncbi Intravenous iron: the iatrogenic kick to lose control over oxygen?
    R Deicher
    Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Wien, Osterreich
    Kidney Blood Press Res 25:284-8. 2002
    ..In this paper, the authors speculate upon potential deleterious effects of intravenous iron on cellular physiology in the setting of the increased oxidant burden of hemodialysis patients...
  3. ncbi Vitamin C in chronic kidney disease and hemodialysis patients
    Robert Deicher
    Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Wien, Osterreich
    Kidney Blood Press Res 26:100-6. 2003
    ..Ascorbate's role in modifying arterial blood pressure remains unclear, but anemic patients with functional iron deficiency might benefit from short-term, moderately dosed ascorbate supplements...
  4. ncbi High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity
    Robert Deicher
    Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria
    Kidney Int 64:728-36. 2003
    ..However, concern exists about possible detrimental effects of parenteral iron on cellular host defense and iron-mediated increments of oxidative stress...
  5. ncbi Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis
    Robert Deicher
    Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Nephrol Dial Transplant 19:2319-24. 2004
    ..This study was performed to analyse the relation between vitamin C plasma concentration and response to rHuEpo...
  6. ncbi Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease
    Robert Deicher
    Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria
    Drugs 64:499-509. 2004
    ..Further studies should be aimed at defining predictors of the individual demand for erythropoietic agents, thereby allowing nephrologists to prescribe a cost-effective, individualised regimen...
  7. ncbi Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients
    Robert Deicher
    Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria
    J Am Soc Nephrol 16:1811-8. 2005
    ..Future studies should address the potential protective effect of an adequate vitamin C supplementation...
  8. ncbi The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients
    Gerald Cohen
    Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria
    Nephrol Dial Transplant 23:2512-9. 2008
    ....
  9. ncbi Anaemia as a risk factor for the progression of chronic kidney disease
    Robert Deicher
    Department of Medicine III, Division of Nephrology and Dialysis, University Hospital of Vienna, Austria
    Curr Opin Nephrol Hypertens 12:139-43. 2003
    ..The urge for more sound clinical intervention trials is met by the ongoing ECAP study (Effect of early Correction of Anaemia on the Progression of chronic kidney disease)...
  10. ncbi Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis
    Bernhard Moser
    Department of Surgery, General Hospital of Vienna, Austria
    Biochem Biophys Res Commun 308:581-5. 2003
    ..These findings strongly suggest that in ESRD patients Th1 T cells are selectively susceptible to undergo apoptosis. This observation provides an additional pathophysiological concept in the genesis of Th2 dominance...
  11. ncbi Hepcidin: a molecular link between inflammation and anaemia
    Robert Deicher
    Nephrol Dial Transplant 19:521-4. 2004
  12. ncbi Vitamin C for hyporesponsiveness to EPO: a cure for all?
    Robert Deicher
    Am J Kidney Dis 42:848; author reply 848-9. 2003